DelMar Pharmaceuticals Inc (NASDAQ:DMPI)

1.03
Delayed Data
As of 3:59pm ET
 +0.03 / +3.00%
Today’s Change
0.78
Today|||52-Week Range
2.98
-5.50%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Zarrabian Saiid
Interim Chief Executive Officer
Buy11/14/201755,000$0.82$45.1K+19.47%
Bacha Jeffrey A
Chief Executive Officer
Buy6/26/20176,700$3.60$24.1K-54.13%
Bell John K
Director
Buy6/06/201710,000$2.12$21.2K-50.98%
Praill Scott
Chief Financial Officer
Buy6/06/20179,500$2.10$20.0K-50.98%
Bell John K
Director
Buy6/26/20174,167$3.60$15.0K-54.13%
Mohr Erich
Director
Buy6/26/20174,167$3.60$15.0K-54.13%
Praill Scott
Chief Financial Officer
Buy6/26/20174,167$3.60$15.0K-54.13%
Praill Scott
Chief Financial Officer
Buy10/05/201717,500$0.85$14.9K+13.64%
Bell John K
Director
Buy11/16/201718,129$0.81$14.7K+24.84%
Bacha Jeffrey A
Chief Executive Officer
Buy6/06/20175,000$2.12$10.6K-50.98%
Page of 2